Maven backs £6.5m buyout of Healthpoint
Maven Capital Partners has backed the ТЃ6.5m management buyout of UK-based healthcare and beauty products supplier Healthpoint.
The deal's capital was raised through Maven's co-investment network and supported by a Barclays financing package consisting of buyout debt and working capital.
Healthpoint's fresh funding will be deployed in support of developing new products and driving organic growth. In a statement, Maven said the company would also consider a buy-and-build strategy with follow-on funding available for bolt-ons.
Company
Headquartered in Blackpool, Healthpoint is a manufacturer of personal care and beauty products.
In addition to its personal care and beauty portfolio, the company also sells over-the-counter medicines under the Healthpoint brand. It expects to expand this product line after Maven's investment.
People
Maven Capital Partners – Ryan Bevington (investment director).
Healthpoint – Amanda Parkinson (managing director).
Advisers
Equity – UNW, Paul Kaiser, Katy Lamb, Stephanie Davidson (corporate finance, tax); Gately, Paul Jefferson, Katie Porter (legal); RPL (commercial due diligence); Vista (insurance due diligence).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds









